BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Broncus Technologies, Inc.: RSNA News: New Tool for Radiologists and Imaging Centers: LungPoint Procedure Planning Revolutionizes Referrals to Chest Physicians


11/30/2009 10:01:30 AM

CHICAGO, IL--(Marketwire - November 30, 2009) -

Broncus Technologies, Inc., a medical device company focused on developing and commercializing innovative solutions for lung diseases, announced today that it is showcasing its LungPoint System at the Radiologic Society of North America (RSNA) Annual Meeting. Radiology departments and imaging centers are expected to benefit from this system. The computer-assisted, image-guided navigation system takes CT scans and provides multi-dimensional reconstructions of the airway tree and virtual animations of pathways to targets or lesions, allowing radiologists to provide much more sophisticated and detailed image reports to referring chest physicians.

"This is an exciting technology because finding an appropriate route through the lung airways to distant targets has long been a challenging aspect of bronchoscopy," explained pulmonologist J. Burr Ross, MD of John C. Lincoln Hospital in Phoenix. "This system will allow radiologists to provide much more comprehensive information to referring physicians which is something pulmonogists and thoracic surgeons will be quite grateful to have."

The LungPoint system also provides tools for the physician to use in reviewing the case with the patient. "Patients really appreciate being able to see exactly the areas in their own lungs that we are concerned about. Reviewing the images and pathways the system generates helps the patient understand the procedure they are about to undergo and puts them at ease," states Dr. Ross.

The system's planning software will help radiologists and imaging centers provide more comprehensive reports to physicians. "We believe that the system will allow radiologists to provide more value and increase their referrals by delivering thorough procedure planning information to lung specialists," states Cary Cole, President and CEO of Broncus Technologies.

About the LungPoint System

The LungPoint Procedure Planning and Virtual Bronchoscopic Navigation system is used to plan and guide bronchoscopic procedures such as lung biopsies and fiducial marker placement. The software gives the physician tools to look at the lungs and airways in three dimensions, resulting in more effective treatment planning and execution. During bronchoscopy, the planned virtual path is compared to the live bronchoscope video images, indicating to the physician the correct airway to follow for optimal biopsy accuracy.

About Broncus Technologies, Inc.

Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Our line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Our patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients.

For more information visit www.broncus.com.

Editors Notes

For more information on LungPoint, the EASE Trial or Broncus Technologies, please contact Meghan Oreste at 617-823-1441 or moreste@comcast.net

Broncus, LungPoint, Yield, and Exhale are trademarks of Broncus Technologies, Inc.


Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES